This session will discuss the challenges of communicating the risk of therapeutic intervention versus the risk and consequences of osteoporotic fracture to your patients. It will identify methods by which to discuss risk with your patients, discuss the incidence of ONJ with bisphosphonate therapy, both IV and oral administration, review means to treat ONJ and discuss therapeutic outcomes, identify common patient questions presented to technologists during a bone density exam, and discuss what information might be relayed to patients in a clinical setting.